Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells

Figure 2

10058-F4 induced cell cycle G1 arrest in ovarian cancer cells. SKOV3 and Hey cells were treated with 10058-F4 at the indicated dose for 48 hours and then analyzed for cell cycle distributions by Cellometer (A and B). Western blotting analysis of cyclinD1, CDK4, CDK6, p21, p27 and β-actin expression in ovarian cancer cells treated with 10058-F4 for 24 hours (C). The alternations of cyclinD1, CDK4, CDK6, p21 and p27 were summarized in D and E. *p < 0.05 and **p < 0.01, two-sided student t test.

Back to article page
\